The dosimetric results and findings described in the T/B ratios of the primary and metastatic lesions suggest that [99mTc]Tc-iFAP imaging is a safe and potentially useful tool to assess FAP expression in the tumor microenvironment of various solid tumors, such as breast, lung, and cervical cancer. This evidence concerns the gene MBTPS2 and cervical cancer.